Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1569 of 6351
-
Can a smartphone app help teen cancer survivors conquer chronic pain?
Symptom relief Recruiting nowThe purpose of the study is to determine if an adapted mobile cognitive behavioral therapy (CBT) app (WebMAP Onc) is more effective than standard pain education in reducing chronic pain and improving daily functioning in adolescent survivors of pediatric cancer. This randomized …
Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Robotic surgery gets a sense of touch: could force feedback speed lung recovery?
Disease control Recruiting nowThe purpose of this research is to study patient outcomes based on the use of Force Feedback instruments during robotic-assisted lung resection. Force Feedback technology describes the physical forces a surgeon senses when pushing and pulling structures inside the body during rob…
Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Clinic culture change aims to boost HIV outcomes for black patients
Disease control Recruiting nowDespite the widespread use of effective antiretroviral therapy (ART), the HIV epidemic continues to impact racial and ethnic minority populations disproportionately. Although Black/African American persons account for 13% of the U.S. population, they account for 41% of new HIV di…
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New stool test aims to catch colorectal cancer early in thousands
Diagnosis Recruiting nowThe post-approval study (PAS) described here will supplement existing data generated in the CRC-PREVENT clinical trial. The primary outcomes of this supplemental study will include: clinical sensitivity, clinical specificity, positive predictive value (PPV), and negative predicti…
Sponsor: Geneoscopy, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Shocking new hope: brain zaps and tablet games may rewire stroke-damaged arms
Symptom relief Recruiting nowStroke is one of the leading causes of long-term disability worldwide. Many individuals who survive a stroke continue to experience weakness and reduced control of one arm, even months or years after the event. These motor impairments significantly affect independence, daily acti…
Sponsor: School of Health Sciences Geneva • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Could a simple scan replace kidney biopsies? new study tests a tracer that sees scarring
Diagnosis Recruiting nowInterstitial fibrosis is a hallmark of progression in chronic kidney disease (CKD), yet it can presently be assessed only by kidney biopsy, which is invasive and prone to sampling error. In recent years the advances in molecular imaging, especially high spatial and temporal reso…
Sponsor: Medical University of Vienna • Aim: Diagnosis
Last updated Jul 19, 2026 00:00 UTC
-
Could two radiation doses beat five for prostate cancer?
Disease control Recruiting nowProstate cancer is a common cancer, and a significant cause of cancer death in men. There are many potentially curative treatment options for prostate cancers that have not spread. A relatively recent option is called prostate stereotactic ablative radiotherapy (SABR). SABR is a …
Phase 2 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Brain zaps for ADHD? new study tests iTBS in children
Symptom relief By invitation onlyThe goal of this clinical trial is to learn if brain stimulation can help children ages 6 to 12 with attention-deficit/hyperactivity disorder (ADHD) improve their attention and self-control. The main questions it aims to answer are: Does intermittent theta burst stimulation (iTB…
Sponsor: Neurolab Plus • Aim: Symptom relief
Last updated Jun 26, 2026 19:15 UTC
-
When to thin the blood after a stroke? new trial seeks answer
Disease control Recruiting nowThis study evaluates the safety and efficacy of early versus delayed initiation of direct oral anticoagulants (DOACs) in patients with acute ischemic stroke related to atrial fibrillation after emergency endovascular therapy (EVT).
Sponsor: Capital Medical University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New heart drug mavacamten tested in indian patients
Disease control OngoingThe purpose of this study is to evaluate the safety, tolerability and effectiveness of mavacamten in adults with obstructive hypertrophic cardiomyopathy in India.
Phase 4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug cocktail targets rare spleen cancer in early trial
Disease control Recruiting now:The aim of this study was to analyze the safety and efficacy of Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma with Prominent Nucleoli (SBLPN). The main questions it aims to explore the Preliminary Efficacy of the …
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Brain wave breakthrough: could smart DBS shorten dystonia treatment tuning?
Knowledge-focused Recruiting nowThe goal of this clinical trial is to learn whether local field potential (LFP) signals recorded from the globus pallidus interna (GPi) using the Medtronic Percept™ deep brain stimulation (DBS) device can help optimize DBS programming for people with dystonia. The study will also…
Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New Immune-Chemo cocktail aims to shrink inoperable lung tumors
Disease control Recruiting nowThis study is a prospective, multicenter, open-label, single-arm Phase II clinical trial. The study recruits patients with stage III unresectable non-small cell lung cancer according to the 8th edition of the AJCC/UICC staging system. It aims to observe and evaluate the efficacy …
Phase 2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can cutting calories or boosting exercise reveal hidden energy crisis in athletes?
Knowledge-focused Recruiting nowThe goal of this clinical trial is to understand how the body responds to short-term, severe low energy availability (LEA) in healthy, weight-bearing endurance athletes aged 18-45 years old. LEA describes a mismatch between an individual's dietary energy intake and the energy cos…
Sponsor: Australian Catholic University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Personalized cell therapy aims to tame type 1 diabetes in early trial
Disease control Recruiting nowThis is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an investigational cell therapy manufactured from a participant's own blood cells in adult participants wit…
Phase 1 • Sponsor: GentiBio, Inc • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New daily pill for kids with ADHD enters key trial
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and examine the safety of two doses of EB-1020 QD XR capsule administered once daily orally in pediatric ADHD patients.
Phase 2/3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New inhaled drug aims to keep bronchiectasis patients Flare-Up free
Disease control Recruiting nowThis study is a phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose range finding study designed to explore the efficacy, safety, and tolerability of 2 active treatment regimens of CSL787 (immunoglobulin G \[IgG\] inhalation solution) compare…
Phase 2 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
VR hypnosis may calm Alzheimer's patients during bath time
Symptom relief Recruiting nowA device combining a virtual reality (VR) headset with hypnotic scenarios may represent an effective tool to reduce anxiety and opposition during hygiene care in patients with neurocognitive disorders presenting with behavioral and psychological symptoms. The primary objective o…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New Antibody-Drug conjugate targets Hard-to-Treat cancers
Disease control Recruiting nowThis is a multicenter, open-label FIH, Phase 1a (dose escalation), Phase 1b (dose expansion) and Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment.
Phase 1/2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Bladder device gets Long-Term safety check
Disease control Recruiting nowProspective, multi-center, single-arm, post-approval study is designed to assess the long-term safety and efficacy data of the Neuspera Sacral Neuromodulation (SNM) System following commercial approval of the Neuspera SNM System. Participants in this study received intervention/…
Sponsor: Neuspera Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC